Abstract
Purpose
To determine the factors related to the clinical outcome of acute endophthalmitis after cataract surgery.
Methods
Authors performed a retrospective study of 65 eyes of 65 patients who had been treated for endophthalmitis from 2001 to 2006 at our hospital. We analyzed the relationship between final visual outcomes and prognostic factors.
Results
Final visual acuities were 0.5 or better in 49.2% of all eyes. Of 57 eyes, 29 eyes (50.8%) were culture positive. Staphylococcus epidermidis and Streptococcus pneumoniae were the most common organisms isolated. Cases with baseline acuity of counting fingers or better, cases with culture-negative or gram-positive infection, and cases not requiring vitrectomy had better prognoses.
References
1. Kim JH. Infectious endophthalmitis, Cataract. 2002. 1st ed. Vol. 1. Seoul: Il Jo Kak;p. 264–72.
2. Diamond JG. Intraocular management of endophthalmitis. A systemic approach. Arch Opthalmol. 1981; 99:96–9.
3. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002; 109:13–24.
4. Ou JI, Ta CN. Endophthalmitis prophylaxis. Ophthalmol Clin North Am. 2006; 19:449–56.
5. Wong TY, Chee SP. The Epidemiology of Acute Endophthalmitis after Cataract Surgery in an Asian Population. Ophthalmology. 2004; 111:699–705.
6. Lalitha P, Rajagopalan J, Prakash K. . Postcataract endophthalmitis in South India incidence and outcome. Ophthalmology. 2005; 112:1884–9.
7. Choi GJ, Yoon GJ, Na KS. Clinical observation on postoperative endophthalmitis following cataract surgery. J Korean Ophthalmol Soc. 1996; 37:961–6.
8. Lee SB, Han JW, Chung SK, Baek NH. factors associated with visual outcomes of postoperative endophthalmitis following cataract surgery. J Korean Ophthalmol Soc. 2005; 46:1628–33.
9. Taban M, Behrens A, Newcomb RL. . acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005; 123:613–20.
10. Soriano ES, Nishi M. endophthalmitis: indicence and prevention. Curr Opin Ophthalmol. 2005; 16:65–70.
11. Yi MW, Kwak NH, Kim MH. . postoperative endophthal- mitis following intraocular surgery. J Korean Opthalmol Soc. 1998; 39:2095–102.
12. Bohigian GM, Olk RJ. factors associated with a poor visual result in endophthalmitis. Am J Ophthalmol. 1986; 101:332–41.
13. The Endophthalmitis Vitrectomy Study Group. microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996; 122:830–46.
14. Rowsey JJ, Newson DL, Sexton DJ. . Endophthalmitis: current approaches. Ophthalmology. 1982; 89:1055–66.
15. Suh DS, Roh JH, Kim SD. surgical management of infectious endophthalmitis: early vitrectomy vs late vitrectomy. J Korean Ophthalmol Soc. 1998; 39:2418–25.
16. Park KS, Park YG, Min WK, Ahn BH. microbiological diagnosis and visual outcome of infectious endophthalmitis. J Korean Ophthalmol Soc. 1994; 35:1715–22.
17. Puliafito CA, Baker AS, Haaf J, Foster CS. infectious endophthalmitis. review of 36 cases. Ophthalmology. 1982; 89:921–9.
18. Endophthalmitis Vitrectomy Study Group; Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995; 113:1479–96.
Table 1.
n (%) | |
---|---|
Gender (male/female) | 30 (46.2%) / 35 (53.8%) |
In-House/Referred | 19 (29.2%) / 46 (70.8%) |
Age (yrs) | |
mean | 65.28±12.34 |
<65 yr | 23 (35.4%) |
≥65 yr | 42 (64.6%) |
Type of surgery | |
ECCE*+PCL† | 11 (16.9%) |
PE‡+PCL | 54 (83.1%) |
Side | |
Right / Left | 29 (44.6%) / 36 (55.4%) |
Follow up (months) | |
mean | 6.08±5.71 |
Diabetes | |
(+) | 13 (20%) |
(-) Initial vision | 52 (80%) |
≥ 0.1 | 14 (21.6%) |
< 0.1 Final vision | 51 (78.4%) |
≥ 0.1 | 40 (77%) |
< 0.1 | 25 (23%) |
Table 2.
Final visual acuity |
||||
---|---|---|---|---|
20/200 to 20/20 | Worse than 20/200 | total | p-value* | |
DM (+) | 10 | 3 | 13 | 0.339 |
DM (-) | 30 | 22 | 52 |
Table 3.
Organism | No. of eyes | ||
---|---|---|---|
No exam | 8 | ||
Culture negative | 28 | ||
Culture positive | Gram positive | Staphylococcus epidermidis | 8 |
Streptococcus sp | 8 | ||
Gram negative | Enterobacter sp | 5 | |
Pseudomonas aeruginosa | 5 | ||
Fungus | 3 |
Table 4.
Final visual acuity |
||||
---|---|---|---|---|
20/200 to 20/20 | Worse than 20/200 | Total | p-value* | |
No growth & gram positive | 30 | 14 | 44 | |
Gram negative & fungus | 4 | 9 | 13 | 0.024 |
Table 5.
Final visual acuity |
||||
---|---|---|---|---|
20/200 to 20/20 | Worse than 20/200 | n Total | p-value* | |
20/20-20/40 | 2 | 0 | 2 | |
20/50-20/200 | 11 | 1 | 12 | |
FC | 10 | 2 | 12 | 0.003 |
HM | 15 | 15 | 30 | |
NLP & LP | 2 | 7 | 9 |
Table 6.
Final visual acuity |
||||
---|---|---|---|---|
20/200 to 20/20 | Worse than 20/200 | Total | p-value* | |
Within 7 days After 8 days | 28 12 | 17 8 | 45 20 | 0.865 |
Table 7.
Final visual acuity |
||||
---|---|---|---|---|
Time to treatment | 20/200 to 20/20 | Worse than 20/200 | Total | p-value* |
Within 2 days After 3 days | 35 5 | 19 6 | 54 11 | 0.311 |